AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
AffyImmune Therapeutics is a business in biopharma, biotechnology, life science based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2016.
AffyImmune Therapeutics is positioned in biopharma, biotechnology, life science, a segment that rewards a clear, focused offering.
Greater Boston Area, East Coast, New England, Northeastern US is where the company is located.
The company is listed at the Series_A stage of development.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $28.9M in funding.
| Sector | Biopharma, Biotechnology, Life Science |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2016 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $28,900,000 |
Website: affyimmune.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account